Literature DB >> 7528563

Lectin and epidermal growth factor domains of P-selectin at physiologic density are the recognition unit for leukocyte binding.

R M Gibson1, G S Kansas, T F Tedder, B Furie, B C Furie.   

Abstract

P-selectin is an integral membrane glycoprotein on stimulated platelets and endothelial cells that serves as a receptor for leukocytes. To estimate the density of P-selectin in membranes necessary to support adhesion, we incorporated purified P-selectin at varying concentrations into phospholipid bilayers that encapsulated glass microspheres. Maximal binding of these lipospheres to HL60 cells, a P-selectin ligand-expressing cell line, was approached at a P-selectin density of about 100 molecules per microns 2; half-maximal binding was observed at about 50 to 60 molecules per microns 2. Compatible results were obtained with P-selectin expressed on Chinese hamster ovary cells. The P-selectin density on stimulated platelets was estimated to be 150 to 200 molecules/microns 2. To identify the domains of P-selectin required for HL60 cell binding, chimeras of P-selectin and L-selectin were stably expressed in Chinese hamster ovary cells and clones that expressed the chimeras at the estimated physiologic density were selected. Chimeras containing the P-selectin lectin and epidermal growth factor (EGF) domains or the lectin, EGF, and short consensus repeats bound HL60 cells equivalently, but a chimera containing the P-selectin lectin domain alone bound HL60 cells much less well. These results indicate that at a physiologically relevant P-selectin density on membrane surfaces, the lectin, and EGF domains of P-selectin are together required for optimal leukocyte binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528563

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

Authors:  Y J Kim; L Borsig; H L Han; N M Varki; A Varki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

2.  P-Selectin: Basic Aspects.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

Review 3.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

Review 4.  The selectins: insights into selectin-induced intracellular signaling in leukocytes.

Authors:  E Crockett-Torabi; J C Fantone
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 5.  Selectin-carbohydrate interactions during inflammation and metastasis.

Authors:  R P McEver
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

6.  Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short complement-like repeat (SCR 4) domain: use of human-mouse chimaera and homologue-replacement mutagenesis.

Authors:  M H Ruchaud-Sparagano; E Malaud; O Gayet; E Chignier; R Buckland; J L McGregor
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

7.  Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of β3 integrins.

Authors:  Jaehyung Cho; Daniel R Kennedy; Lin Lin; Mingdong Huang; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Blood       Date:  2012-05-31       Impact factor: 22.113

8.  Visualization of allostery in P-selectin lectin domain using MD simulations.

Authors:  Shouqin Lü; Yan Zhang; Mian Long
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

Review 9.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

10.  Variation in the upstream region of P-Selectin (SELP) is a risk factor for SLE.

Authors:  D L Morris; R R Graham; L-P Erwig; P M Gaffney; K L Moser; T W Behrens; T J Vyse; D S Cunninghame Graham
Journal:  Genes Immun       Date:  2009-04-30       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.